Hadassah

BioLineRx to Commence Phase 1 Stem Cell Trial at Hadassah Medical Organization

Thursday, Jun 19 2014

BioLineRx Ltd. has received approval from the Israeli Ministry of Health to commence a Phase 1 trial for BL-8040, a novel treatment for mobilizing stem cells from the bone marrow for treating acute myeloid leukemia, as well as other hematological malignancies. The study is expected to begin during the third quarter of 2014 at the Hadassah Medical Organization.

Dr. Kinneret Savitsky, Chief Executive Officer of BioLineRx, explains that stem cell mobilization is being used more and more as a method of collecting stem cells, instead of the traditional surgical procedure of bone marrow harvesting. Current treatment regimens, she notes, involve daily injections of G-CSF, a growth factor that stimulates the bone marrow to make white blood cells.

These injections are given for 4-6 days with or without the addition of a mobilizing agent such as Plerixafor (Mozobil). A previous Phase 1/2 study in multiple myeloma patients revealed that BL-8040 given as a single injection in combination with G-CSF injections was highly effective in mobilizing stem cells. The current trial aims to evaluate the mobilization capacity of one or two injections of BL-8040 as a stand-alone therapy, which could significantly shorten treatment and reduce costs.

Comments

No comments yet.
First Name
Email
Comment
Enter this word:

Related Stories

alt_text

Friday, Sep 21 2018

Hadassah Numbers to Commend and Celebrate

Over the past year, Hadassah Medical Center researchers received over 60 percent of the National Science Foundation Awards for biomedical research in Israeli hospitals...

READ MORE ›
alt_text

Thursday, Sep 20 2018

NanoKnife® Technology to Treat Prostate Cancer Comes to Hadassah

NanoKnife® technology, the most innovative method for treatment of localized prostate cancer, is now being applied at the Hadassah Medical Organization, making Hadassah the first in Israel to treat prostate cancer in this minimally invasive way.

READ MORE ›
alt_text

Thursday, Sep 20 2018

Car-ramming Victim and His Family Give Thanks

Life in the Horaling family changed forever on November 17, 2017. Dad Ebenezer Horaling, 35, was taking a bus to work as a custodian at a boys’ junior high school 20 minutes away from his home. Ebenezer had gotten off the bus and was walking to the school when a 17-year-old terrorist drove into him, throwing him into the air.

READ MORE ›
alt_text

Thursday, Sep 20 2018

Hadassah Director General Organizes Surprise for Hospitalized Children

Providing a respite from medical treatment during this holiday season, a collection of antique cars suddenly appeared on the lawns of Hadassah Hospital Ein Kerem, and the hospitalized children and their families were invited to take a close look.

READ MORE ›

Donation Questions

donorservices@hadassah.org

(800) 928-0685

Membership Questions

membership@hadassah.org

(800) 664-5646

Missions Department

missions@hadassah.org

(800) 237-1517

Contact Us

40 Wall Street

New York, NY 10005

support@hadassah.org

More ›

Show More